- This narrative review summarizes evidence on GLP-1 receptor agonist delayed gastric emptying and proposes a pharmacist-led perioperative risk framework.
- GLP-1 receptor agonists may leave residual gastric contents despite standard fasting, yet outcome studies have not consistently shown more aspiration pneumonia.
- These aspiration findings are limited by rare events, mostly retrospective designs, residual confounding, and inconsistent definitions of residual gastric contents.
- The proposed pathway covers medication verification, symptom screening, risk phenotyping, selective gastric ultrasound, and restart planning, and the authors call for prospective testing.
Perioperative medicine
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Retrospective cohort of 147 women aged 65 or older undergoing modified radical mastectomy: 78 received PSPB plus serratus anterior blocks, and 69 had no regional anesthesia.
- At 6 months, the block group had lower QuickDASH scores (7.8 vs 18.7, p<0.001) and better flexion and abduction, but Constant-Murley scores did not differ (p=0.682).
- Persistent stiffness occurred less often with blocks (42.3% vs 69.6%, p=0.002), and regional blockade was an independent protective factor (OR 0.29, 95% CI 0.14-0.59, p=0.001).
- The authors describe an association between regional anesthesia and better functional recovery but state that causality cannot be established given the retrospective design.
- Prospective, open-label randomized trial of 105 adults aged 60 or older with moderate renal insufficiency undergoing elective OPCAB, split equally into three groups.
- Dexmedetomidine 0.4 μg/kg/h without a loading dose and dopamine 3 μg/kg/min were each compared with a normal saline control, infused from induction through 24 postoperative hours.
- Dexmedetomidine raised urine output (p < 0.01) and eGFR (p < 0.0001) versus dopamine and control at days 1 and 2; creatinine and BUN differences were not clinically significant.
- No group developed AKI by AKIN criteria, adverse events were similar across groups (p = 0.31), and the authors conclude neither drug prevented AKI beyond control.
- Single-center, unadjusted retrospective cohort of 113 consecutive open TAAA repairs, comparing 86 prebundle patients with 27 patients managed under the BARTAAAKI bundle.
- The intervention was a perioperative renal protection bundle, a modified KDIGO-based protocol, compared with the prebundle period.
- Stage 2-3 AKI at 72 hours was less frequent after the bundle (56% vs 80%; risk difference -25 points, 95% CI -44 to -5; p = 0.02), and renal recovery at discharge was more frequent (93% vs 69%; +24 points, 95% CI +6 to +36; p = 0.01).
- Renal replacement therapy did not differ significantly (41% vs 52%; p = 0.38), and the authors call for prospective confirmation of these unadjusted findings.
- This structured narrative review searched MEDLINE, Embase, Scopus and Web of Science through November 2025, supplemented by public health alerts, toxicology reports and drug-checking data.
- Drug-laced vaping delivers non-nicotine psychoactive substances such as cannabinoids, stimulants, opioids and benzodiazepines, sometimes without the user knowing, and routine toxicology may miss them.
- The authors group reported perioperative concerns into airway and lung injury, autonomic and cardiovascular instability, and altered consciousness with ventilatory compromise.
- Emerging synthetic cannabinoids and designer benzodiazepines may evade immunoassays, and the authors offer pragmatic checklists for preoperative, intraoperative and postoperative care.
- Retrospective single-center review of 245 pediatric patients aged 18 or younger who had isolated liver transplantation between 2013 and 2021.
- Patients were grouped by extubation timing: 33 immediate intraoperative, 110 early within 24 hours, and delayed extubation after 24 hours as the comparator.
- The immediate and early extubation group had significantly shorter ICU and hospital stays than the delayed group, and no patients were reintubated.
- Age, preoperative care setting, and intraoperative regional anesthesia independently predicted successful early extubation, with a C-statistic of 0.82 (95% CI 0.77–0.88).
- This preclinical study used an LPS-induced inflammatory cognitive impairment model in mice, created by intracerebroventricular injection; the abstract does not report sample size.
- Mice received semaglutide alone or combined with the O-GlcNAc transferase inhibitor OSMI-1 and AKT-silencing adeno-associated viruses.
- Semaglutide reversed LPS-induced cognitive deficits and restored hippocampal O-GlcNAcylation, though the abstract reports no effect sizes or statistics.
- The authors conclude that semaglutide ameliorates perioperative neurocognitive disorder through AKT O-GlcNAcylation, AKT-mTOR activation, and downstream neuroprotection.
- This retrospective PearlDiver database study included 95,566 primary total shoulder arthroplasty patients, of whom 1,549 (1.62%) were GLP-1 receptor agonist users.
- GLP-1 users were compared with non-users after 10:1 exact matching on age, sex, Elixhauser index, diabetes, hypertension and overall obesity, with multivariable adjustment for remaining imbalances.
- After adjustment, no significant differences in medical or orthopaedic complications were found, while GLP-1 users had lower 90-day ED visit (OR 0.75; P < .01) and readmission (OR 0.71; P < .01) odds.
- The authors concluded GLP-1 use was not associated with worse outcomes and may be linked to lower healthcare utilisation, though obesity-class subgroup differences were not significant, likely due to small size.
- Retrospective cohort from the TriNetX US network of adults having major solid tumour surgery from 2014 to 2023, with 29,547 propensity-matched pairs drawn from 176,149 eligible patients.
- Perioperative ketamine on the day of surgery was compared with matched patients who did not receive it.
- Ketamine was not associated with lower 3-year mortality (16.7% vs 16.0%; HR 1.04; 95% CI 1.00-1.09; q=0.187), and 5-year mortality did not differ.
- An exploratory composite of cancer-progression surrogates was lower with ketamine (HR 0.82; 95% CI 0.74-0.92; q=0.013), but the authors conclude there was no mortality benefit.
- International, double-blind, placebo-controlled randomised trial of 955 adults with anaemia awaiting elective cardiac surgery, across 33 hospitals in 10 countries.
- Participants were randomised to 1000 mg intravenous iron or placebo 1 to 26 weeks before surgery.
- Days alive and at home at 90 days were 81.1 with iron versus 80.0 with placebo (adjusted median difference 1.0 day, 95.4% CI 0.0 to 2.1, P=0.041).
- Transfusion during hospital stay was 61.1% with iron versus 68.2% with placebo (RR 0.90, 95% CI 0.82 to 0.99, P=0.027); complications and stay did not differ.
- This single-centre prospective diagnostic accuracy study enrolled 100 adults undergoing elective cardiac surgery with cardiopulmonary bypass.
- The study assessed whether the Quantra QPlus platelet contribution to clot stiffness could predict a composite of postoperative thrombocytopenia or platelet dysfunction on PFA-200.
- Overall prediction was modest (ROC-AUC 0.61, 95% CI 0.50-0.72), while thrombocytopenia was predicted well (AUC 0.89, 95% CI 0.82-0.97) but platelet dysfunction was not (AUC 0.59).
- The authors conclude that the measure does not detect bypass-induced platelet dysfunction, though it may serve as a point-of-care surrogate for platelet count.
- This is a narrative review of glucagon-like peptide-1 receptor (GLP-1) agonists in patients undergoing surgery.
- It covers the history and mechanism of action of these drugs, then recent evidence and perioperative management strategies.
- The abstract highlights delayed gastric emptying and the resulting aspiration risk during anesthesia as the central concern, but reports no specific findings or numbers.
- Systematic review and meta-analysis of 27 studies (n = 21,908) of children under 18 undergoing noncardiac surgery, assessing KDIGO-defined AKI within 7 postoperative days.
- Pooled incidence was reported separately by population because overall pooling was judged uninterpretable given heterogeneity (I² = 98.7%).
- Reported incidence was 22.3% (95% CI 11.2-39.3) after neonatal surgery, 30.1% (95% CI 21.4-40.6) after pediatric liver transplantation, and 9.2% (95% CI 3.3-23.6) in mixed pediatric surgical populations.
- Within mixed surgical populations, AKI rose with higher ASA class (2.4% in ASA 1-2 to 18.9% in ASA 4-5) and fell with age; the authors conclude the true incidence remains uncertain, with certainty rated low to very low.